Sign In
Buy SNY
$41.60
-0.180 (-0.431%)
At Close: Jun 23, 2026
Sanofi (SNY) Gets FDA Approval for Sarclisa Label Expansion
09:51am, Thursday, 01'st Apr 2021
Sanofi's (SNY) Sarclisa gets FDA approval to treat multiple myeloma patients who have received one to three prior lines of therapy in combination with Kyprolis and dexamethasone.
PARIS, March 31, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Sarclisa® (isatuximab-irfc) in combination with carfilzomib and dexamethasone (Kd), for the treatment
Daiichi Axes Sanofi Vaccine Pact After Pertussis Jab Manufacturing Faces Snag
01:46pm, Wednesday, 31'st Mar 2021
Though Daiichi Sankyo (OTCMKTS: DSNKY) and Sanofi SA (NASDAQ: SNY) came forward to help produce other pharmas' COVID-19 shots, the companies are calling it quits on their own, separate vaccine al
Canadian Government, Sanofi To Build C$925M Flu Vaccine Facility In Toronto
11:57am, Wednesday, 31'st Mar 2021
Sanofi SA (NASDAQ: SNY) is dropping a major investment into its supply chain by shelling C$925 million to build a new manufacturing facility in Toronto. The new facility will be operational by 202
